Content 1/2003

Progress in Xenotransplantation Research Employing Transgenic Pigs
H. Niemann, W. A. Kues
Cyclosporine C2-Monitoring for Optimisation of Immunosuppression in Renal Transplantation – Recommendations According to First Experience in German Centers
B. Nashan, V. W. Armstrong, K. Budde, L. Fricke, U. Heemann, R. Lück, E. Röthele, E. H. Scheuermann, B. Suwelack
Acute Phase Proteins in Transplant Patients – Review
M. Sobiesiak
Serum Levels of Myeloid-Related Protein 8/14 (MRP8/14): Dynamics and Diagnostic Relevance after Kidney Transplantation
J. Kaden, G. May, V. Strobelt, S. Mauracher, A. Zecher, C. Wesslau
Lymphocyte/Plasma Cell Accumulation and Expression of the B-Cell Specific Chemokine MIP-3a/CCR-6 in Acute Liver Allograft Rejection
M. G. Krukemeyer, L. Morawietz, M. Harren, C. Radke, P. Gratze, P. Neuhaus, V. Krenn
Feasibility of a New Technique of Reperfusion in Liver Transplantation
D. Kniepeiss, F. Iberer, S. Schaffellner, E. Jakoby, D. Duller, K.-H. Tscheliessnigg
Possible Consequences from Commercialisation of Organ Donation within Medical Profession
F. Weber
Living Donor Kidney Transplantation: Chance for the Recipient – Financial Risk for the Donor?
N. Senninger, H. H. Wolters
Prion Induced Diseases
S. Poser, M. Bartl, U. Jastrow, K. Körtner, B. Mollenhauer, M. Schneider-Dominco, I. Zerr
